Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ambrosi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|March 30, 2022
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancerMartina Mazzeschi, Michela Sgarzi, Donatella Romaniello, et al.
NPJ Precision Oncology|April 8, 2026
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapyFederica Pagano, Cinzia Girone, Francesco Borrelli, et al.
American Journal of Clinical Pathology|September 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumorsSofia Melotti, Francesca Ambrosi, Tania Franceschini, et al.
Virchows Archiv : an International Journal of Pathology|March 19, 2026
Mucosal melanoma of the head and neck region: clinical-pathologic implications of tumor microenvironment evaluated with multiplex immunohistochemistryCostantino Ricci, Barbara Corti, Ernesto Pasquini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2026
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysisPietro Bertoglio, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2025
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trialsFrancesco Guerrera, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Virchows Archiv : an International Journal of Pathology|June 18, 2026
Immunohistochemical characterization of somatically derived "yolk sac tumors": analysis of a multi-institutional case seriesCostantino Ricci, Antonio De Leo, Marco Grillini, et al.
Histopathology|April 15, 2025
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck regionCostantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2023
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOTCostantino Ricci, Francesca Ambrosi, Tania Franceschini, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Experimental & Clinical Cancer Research : CR|March 30, 2022
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancerMartina Mazzeschi, Michela Sgarzi, Donatella Romaniello, et al.
NPJ Precision Oncology|April 8, 2026
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapyFederica Pagano, Cinzia Girone, Francesco Borrelli, et al.
American Journal of Clinical Pathology|September 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumorsSofia Melotti, Francesca Ambrosi, Tania Franceschini, et al.
Virchows Archiv : an International Journal of Pathology|March 19, 2026
Mucosal melanoma of the head and neck region: clinical-pathologic implications of tumor microenvironment evaluated with multiplex immunohistochemistryCostantino Ricci, Barbara Corti, Ernesto Pasquini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2026
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysisPietro Bertoglio, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2025
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trialsFrancesco Guerrera, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Virchows Archiv : an International Journal of Pathology|June 18, 2026
Immunohistochemical characterization of somatically derived "yolk sac tumors": analysis of a multi-institutional case seriesCostantino Ricci, Antonio De Leo, Marco Grillini, et al.
Histopathology|April 15, 2025
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck regionCostantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2023
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOTCostantino Ricci, Francesca Ambrosi, Tania Franceschini, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Pageof 7